Study identifies new biomarker for diabetic kidney disease

April 9, 2014

Drs. Chris Kennedy and Dylan Burger published a paper in the Journal of the American Society of Nephrology that identifies a novel urinary biomarker for diabetic kidney disease. Drs. Burger and Kennedy showed that specialized kidney cells called podocytes, which form the main filter of the kidney, release tiny bits of themselves (called micro-particles) into the urine when stressed under diabetic conditions in mice. These micro-particles can be detected even before the earliest signs of diabetic kidney disease become apparent. Testing for these micro-particles could potentially identify patients who are at risk of developing more advanced kidney damage. This paper was also the subject of an editorial in the journal.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)